Healthcare Equipment and Supplies
Company Overview of Lackawanna Biosciences
Lackawanna Biosciences markets and manufactures Staphage Lysate (SPL) , a licensed immuno-modulator meant for staph related infections, to treat Chronic Fatigue Syndrome, Fibromyalgia, and other disorders that stem from chronic staph infections in the US and Europe. Lackawanna Biosciences is based in Clarks Summit, Pennsylvania.
Clarks Summit, PA
Key Executives for Lackawanna Biosciences
Lackawanna Biosciences does not have any Key Executives recorded.
Similar Private Companies By Industry
|.decimal, Inc.||United States|
|20/20 GeneSystems, Inc.||United States|
|20/20 Imaging LLC||United States|
|21st Century Scientific, Inc.||United States|
|21X Corporation||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
To contact Lackawanna Biosciences, please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.